Premarket Approval (PMA) Summary Review Memos for 180-Day Design Changes
-
As a pilot program under the CDRH Transparency Initiative, FDA has begun releasing some summary review memos for 180-day PMA supplements relating to design changes. Links to all available summary review memos can be found here.
6 to 10 of 325 records |
|
Device
Name |
PMA
Number |
Decision
Date |
Review Memo |
Approval Order |
---|---|---|---|---|
restylane l and perlane l injectable gels | P040024/S039 | 01/29/2010 | Review | Approval |
epic hf crt-d system | P030054/S131 | 01/29/2010 | Review | Approval |
cadence family of icds | P910023/S215 | 01/29/2010 | Review | Approval |
paradym vr model 8250 & dr model 8550 | P980049/S050 | 04/07/2010 | Review | Approval |
paradym crt-d model 8750 | P060027/S015 | 04/07/2010 | Review | Approval |
Other Databases
- 510(k)s
- De Novo
- Medical Device Reports (MAUDE)
- CDRH Export Certificate Validation (CECV)
- CDRH FOIA Electronic Reading Room
- CFR Title 21
- CLIA
- Device Classification
- FDA Guidance Documents
- Humanitarian Device Exemption
- Medsun Reports
- Premarket Approvals (PMAs)
- Post-Approval Studies
- Postmarket Surveillance Studies
- Radiation-Emitting Products
- Radiation-Emitting Electronic Products Corrective Actions
- Recalls
- Registration & Listing
- Standards
- Total Product Life Cycle
- X-Ray Assembler
-